Symbol Lookup

Tuesday April 28, 2015 11:53 AM ET. Data delayed 15 minutes.
0.20
-0.02 (-9.59%)
Bid/Lots
0.20/100
Ask/Lots
0.20/200
Open/Prev Close
0.22/0.22
Day Range
0.20-0.22
52-Week Range
0.13-0.60
Vol/Avg Daily Vol
368.9K/644.8K
  • TSX Comp
  • TSX Venture
  • DJIA
  • S&P 500
  • NASDAQ
Price Comparison Chart
Data delayed at least 15 minutes.

Recent News»

0 New Today
Penny Stocks Alerts for NEW GENERATION CONSU, Vapor Group, Guided Therapeutics, Jammin Java, MassRoots, and Max Sound
8:45AM ET on Tuesday Apr 21, 2015 by PR Newswire

Pennystocksinsiders.com (PSI) released FREE insider trading reports for US market investors to track the following active stocks and penny stocks: NEW GENERATION CONSU (OTCMKTS:NGCG), Vapor Group (OTCMKTS:VPOR), Guided Therapeutics (OTCBB:GTHP)...

Canadian Pilot Programs Initiated with LuViva(R) Advanced Cervical Scan for Provincial-level Cancer Care Support
8:05AM ET on Tuesday Apr 21, 2015 by Business Wire

Guided Therapeutics, Inc. (OTCBB: GTHP) (OTCQB: GTHP), announced today an initiative for procuring provincial-level support for its LuViva Advanced Cervical Scan. The initiative is based on discussions with women's h...

Guided Therapeutics Completes Interim Financing; Initiating Distribution of LuViva(R) Advanced Cervical Scan in China
8:05AM ET on Wednesday Apr 15, 2015 by Business Wire

Guided Therapeutics, Inc. (OTCBB: GTHP) (OTCQB: GTHP), announced today it has completed the sale of 4.0 million shares of our common stock and warrants to purchase an additional 2.0 million shares, for an aggregate purchase...

Guided Therapeutics Ships First Commercial LuViva(R) Advanced Cervical Scans to Indonesia
8:05AM ET on Wednesday Apr 08, 2015 by Business Wire

Guided Therapeutics, Inc. (OTCBB: GTHP) (OTCQB: GTHP), announced today it has shipped two LuViva(R) Advanced Cervical Scans to Indonesia to begin cervical cancer screening evaluations in the world's fourth most populous cou...

Company Information

Guided Therapeutics, Inc. is a medical technology company focused on developing medical devices. The Company’s primary focus is the development of its LuViva non-invasive cervical cancer detection device and extension of its cancer detection technology into other cancers, especially esophageal. The Company’s technology, including products in research and development, primarily relate to biophotonics technology for the non-invasive detection of cancers. LuViva is a non-invasive cervical cancer detection product, based on the Company's biophotonic technology. The device is designed to identify cervical cancers and precancers painlessly, non-invasively and at the point-of-care by scanning the cervix with light, then analyzing the light reflected or emanating from the cervix.  The Company's product, in addition to detecting the structural changes attributed to cervical cancer, is also designed to detect the biochemical changes that precede the development of visual lesions.

CONTACT INFORMATION

Headquarters5835 Peachtree Cors E Ste D
NORCROSS, GA, United States 30092-3413
Phone770-242-8723
Fax--

EXECUTIVE OFFICERS

Independent Chairman and DirectorMichael James
Chief Executive Officer, Acting Chief Financial Officer, President and DirectorGene Cartwright
Senior Vice President - EngineeringRichard Fowler
Independent DirectorRonald Hart
Independent DirectorJohn Imhoff

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Stocks Ratings Sample

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

  •  
  • INK Company Insider

    Detailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®

  • S&P Capital IQ Stock Report

    S&P Capital IQ's analysts' overview and valuation, with key fundamental, quantitative, and technical analysis.

  • TDSI Morning Action Notes

    Morning Institutional Report of company updates and new recommendations.

Market Cap$21.4MBeta0.41
Revenue (TTM)$823.0KEPS$-0.13
Shares Out.97.2MBook Value$-0.05
Guided Therapeutics Inc does not pay a dividend.P/E--
Price/Sales (TTM)26.0
P/Cash Flow (TTM)--
Operating Margin-1,092.83%

*GAAP = prior to non-GAAP analyst adjusted earnings.

(Non-GAAP)*

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Stocks Calendar Sample